Neal Pawar - 01 Mar 2024 Form 4 Insider Report for Enfusion, Inc.

Role
Chief Operating Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Mar 2024
Net transactions value
$0
Form type
4
Filing time
05 Mar 2024, 20:25:47 UTC
Previous filing
29 Nov 2023
Next filing
02 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +144,176 +14% $0.000000 1,184,571 01 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 296,143, 296,143, 296,143 and 296,143 on each of March 1, 2025, 2026, 2027 and 2028.